ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,960 | -56.0% | 25,742 | -35.4% | 0.00% | – |
| Q4 2022 | $6,732 | -15.8% | 39,838 | +0.9% | 0.00% | – |
| Q3 2022 | $8,000 | -60.0% | 39,496 | -0.0% | 0.00% | – |
| Q2 2022 | $20,000 | -16.7% | 39,512 | -3.8% | 0.00% | – |
| Q1 2022 | $24,000 | +14.3% | 41,092 | +18.9% | 0.00% | – |
| Q4 2021 | $21,000 | +61.5% | 34,556 | +166.8% | 0.00% | – |
| Q3 2021 | $13,000 | +8.3% | 12,951 | +17.0% | 0.00% | – |
| Q2 2021 | $12,000 | +20.0% | 11,070 | +0.6% | 0.00% | – |
| Q1 2021 | $10,000 | +100.0% | 11,000 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | -44.4% | 11,000 | 0.0% | 0.00% | – |
| Q3 2020 | $9,000 | +50.0% | 11,000 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | +50.0% | 11,000 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -50.0% | 11,000 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | 0.0% | 11,000 | 0.0% | 0.00% | – |
| Q3 2019 | $8,000 | -50.0% | 11,000 | -10.7% | 0.00% | – |
| Q2 2019 | $16,000 | -40.7% | 12,323 | -3.8% | 0.00% | – |
| Q1 2019 | $27,000 | +8.0% | 12,810 | +16.5% | 0.00% | – |
| Q4 2018 | $25,000 | -35.9% | 11,000 | 0.0% | 0.00% | – |
| Q3 2018 | $39,000 | +143.8% | 11,000 | +119.6% | 0.00% | – |
| Q2 2018 | $16,000 | -11.1% | 5,009 | +0.2% | 0.00% | – |
| Q1 2018 | $18,000 | -18.2% | 5,000 | 0.0% | 0.00% | – |
| Q4 2017 | $22,000 | -15.4% | 5,000 | 0.0% | 0.00% | – |
| Q3 2017 | $26,000 | -3.7% | 5,000 | -4.1% | 0.00% | – |
| Q2 2017 | $27,000 | +2600.0% | 5,216 | +2110.2% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 236 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 236 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | -50.0% | 236 | -33.1% | 0.00% | – |
| Q4 2015 | $2,000 | -75.0% | 353 | -82.4% | 0.00% | – |
| Q1 2015 | $8,000 | +14.3% | 2,000 | +33.3% | 0.00% | – |
| Q3 2014 | $7,000 | -12.5% | 1,500 | -12.7% | 0.00% | – |
| Q2 2014 | $8,000 | – | 1,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital CS Group, LLC | 75,669 | $38,000 | 0.04% |
| Founders Capital Management | 18,000 | $9,000 | 0.01% |
| Verdence Capital Advisors LLC | 58,382 | $29,000 | 0.00% |
| WOLFF WIESE MAGANA LLC | 10,740 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 93,669 | $47,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 171,928 | $86,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 25,210 | $13,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $50,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $5,000 | 0.00% |